logo
Select company
Select metric
-131.08%Free Cash Flow Margin
VS
Market
11
Sector
35
Industry
64
History
68
$ 18Close
$ 3.93 - $ 21.42 52-Week Range
Ticker Information

Ticker

URGN

Company Name

UROGEN PHARMA LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

UROGEN PHARMA LTD - Free Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

URGN - FCF % Historical data
DateFree Cash FlowFree Cash Flow MarginRevenues
6/30/2025$ -123.53M-131.08%$ 94.24M
3/31/2025$ -107.39M-116.9%$ 91.87M
12/31/2024$ -97.06M-107.37%$ 90.4M
9/30/2024$ -96.38M-107.85%$ 89.36M
6/30/2024$ -86.02M-101.18%$ 85.01M
3/31/2024$ -82.47M-97.83%$ 84.3M
12/31/2023$ -76.57M-92.57%$ 82.71M
9/30/2023$ -85.28M-110.36%$ 77.28M
6/30/2023$ -85.65M-118.1%$ 72.52M
3/31/2023$ -89.62M-131.83%$ 67.98M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • UROGEN PHARMA LTD's latest trailing twelve months (TTM) FCF % stands at -2918.84%.
  • Over the past 5 years, UROGEN PHARMA LTD's average FCF % has been -336.13%.
  • The median FCF % for UROGEN PHARMA LTD during this period was -134.14%
  • UROGEN PHARMA LTD reached its highest FCF % over the past 5 years at -92.57%.
  • The lowest FCF % recorded by UROGEN PHARMA LTD in the same timeframe -2918.84%

UROGEN PHARMA LTD's FCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF % Benchmarks
CompanyFCF %
NRIX : NURIX THERAPEUTICS INC -288.41%SNDX : SYNDAX PHARMACEUTICALS INC -387.14%GYRE : GYRE THERAPEUTICS INC 0.07%CRMD : CORMEDIX INC 25.03%NAGE : NIAGEN BIOSCIENCE INC 18.02%ZYME : ZYMEWORKS INC -32.93%PHAT : PHATHOM PHARMACEUTICALS INC -241.02%TBPH : THERAVANCE BIOPHARMA INC 317.05%WVE : WAVE LIFE SCIENCES LTD -213.01%KURA : KURA ONCOLOGY INC 147.53%

Definition of Free Cash Flow Margin

[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
FCF / Revenues
(=) FCF %
FCF % for UROGEN PHARMA LTD is calculated as follows: FCF [ $ -111.88M ] / Revenues [ $ 3.83M ]
(=) FCF % [ -2918.84% ]

URGN - Free Cash Flow Margin, Last 5 years

-2918.84%

Minimum

Sep 30, 2020

-92.57%

Maximum

Dec 31, 2023

-336.13%

Average

-134.14%

Median

FCF % Benchmark Analysis

The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.86% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
filtered constituents3.18K
min-58.23%
max68.19%
average7.86%
median7.37%
std19.48%